
Keywords: cAMP; Adrenomedullin; Receptor activity-modifying protein; Calcitonin gene-related peptide; Oxygen-induced retinopathy; Choroidal neovascularisation; AM; adrenomedullin; AMD; age-related macular degeneration; ApoE; apolipoprotein E; cAMP; cyclic adenosine monop